dr. shore on challenges with adt in recurrent prostate cancer
Published 4 years ago • 197 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
5:59
challenges associated with adt for prostate cancer
-
5:21
challenges associated with adt in prostate cancer
-
1:08
dr. shore on unique challenges in nonmetastatic crpc
-
6:42
dr. shore on clinical trial challenges
-
12:11
triggers to initiate androgen-deprivation therapy (adt) in prostate cancer
-
6:40
considerations for initiating adt in prostate cancer
-
1:18
dr. aggarwal on the future of adt for patients with prostate cancer
-
0:29
the role of adt in prostate cancer recurrence
-
4:12
optimal adt for patients with prostate cancer and cv history
-
1:47
dr. oh on remaining challenges with docetaxel in prostate cancer
-
1:53
dr. nguyen on the optimal duration of adt in high-risk prostate cancer
-
39:50
risks of adt in recurrent prostate cancer
-
1:11
dr. burgess on the synergy between abiraterone and adt in prostate cancer
-
6:14
intermittent versus continuous androgen-deprivation therapy in prostate cancer
-
40:09
adt as foundational therapy: consistent t suppression, goals, monitoring, and delaying time to crpc
-
6:24
age, exercise, and adt for prostate cancer
-
1:24
dr. tward on abbreviated course adt for prostate cancer
-
3:50
considering adt’s role in advanced prostate cancer
-
1:07
dr. abdenour nabid on shorter duration of adt in prostate cancer